Dextromethorphan-bupropion (Auvelity) for the Treatment of Major Depressive Disorder

This publication has 14 references indexed in Scilit:

• Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression
  JAMA Psychiatry, 2022
• Analysis of Time-Course, Dose-Effect, and Influencing Factors of Antidepressants in the Treatment of Acute Adult Patients With Major Depression
  International Journal of Neuropsychopharmacology, 2019
• Dextromethorphan/Bupropion: A Novel Oral NMDA (N-methyl-d-aspartate) Receptor Antagonist with Multimodal Activity
  CNS Spectrums, 2019
• Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
  The Lancet, 2018
• The sigma-1 receptor: roles in neuronal plasticity and disease
  Trends in Neurosciences, 2012
• Rates of 5 Common Antidepressant Side Effects Among New Adult and Adolescent Cases of Depression: A Retrospective US Claims Study
  Clinical Therapeutics, 2012
• Combination of Antidepressant Medications From Treatment Initiation for Major Depressive Disorder: A Double-Blind Randomized Study
  American Journal of Psychiatry, 2010
• Dextromethorphan abuse: Clinical effects and management
  Journal of the American Pharmacists Association, 2009
• Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
  American Journal of Psychiatry, 2006
• Evaluation of the reinforcing properties and phencyclidine-like discriminative stimulus effects of dextromethorphan and dextrorphan in rats and rhesus monkeys
  Psychopharmacology, 1999